The Evolving Role of Epoetin Alfa in Cancer Therapy

The Evolving Role of Epoetin Alfa in Cancer Therapy David H. Henry Oncologist 2004; 9: 97-107 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in symptom management and supportive care and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Describe the use of epoetin alfa in the prevention and treatment of anemia related to cancer and its treatment. Discuss ongoing clinical issues with epoetin alfa, including alternative dosing options and the benefits of early intervention for anemia. Identify additional nononcologic clinical applications for epoetin alfa currently under investigation. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Jan. 30, 2004 Most Recent Review: Jan. 30, 2004* Most Recent Update: Jan. 30, 2004 Date Credit Expires: Apr. 10, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.